MORE
Dosing Guide
Product-Details-Purchase

Product Details & Purchase

Cytopoint-Pet-Owner-Website

Cytopoint® Pet Owner Website

Veterinary-Professional-Website

Apoquel® (oclacitinib tablet) Veterinary Professional Website
Apoquel-Pet-Owner-Website

Apoquel Pet Owner Website

Cytopoint Indications

Cytopoint has been shown to be effective for the treatment of dogs against allergic dermatitis and atopic dermatitis.

Apoquel Indications

Control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.

Apoquel Important Safety Information

Do not use Apoquel in dogs less than 12 months of age or those with serious infections. Apoquel may increase the chances of developing serious infections, and may cause existing parasitic skin infestations or pre-existing cancers to get worse. Consider the risks and benefits of treatment in dogs with a history of recurrence of these conditions. New neoplastic conditions (benign and malignant) were observed in clinical studies and post-approval. Apoquel has not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporines. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. Apoquel has been used safely with many common medications including parasiticides, antibiotics and vaccines.

For more information, please see the full Prescribing Information.

Cytopoint® Safety

Cytopoint is a safe choice for dogs with allergic pruritus1

Cytopoint was shown to be safe and effective in an independent, real-world study of dogs with allergic dermatitis1

  • Safe to use in dogs of any age
  • Cytopoint was used safely in a study in combination with other medications, including2:
    • Parasiticides, antibiotics, antifungals, corticosteroids, vaccines, immunotherapy, antihistamines and other antipruritics

Adverse health events were comparable to placebo in client-owned dogs2*

Adverse events reported in >2% of dogs in a field safety study2†
ABNORMAL HEALTH EVENTPREFERRED TERM
PLACEBO(n=83 dogs)
CYTOPOINT(n=162 dogs)
Otitis externa
12% (10)
13% (21)
Dermatitis
13.3% (11)
9.9% (16)
Bacterial skin infection
12% (10)
9.3% (15)
Erythema
4.8% (4)
8% (13)
Vomiting
10.8% (9)
7.4% (12)
Anorexia
4.8% (4)
6.2% (10)
Lethargy
6% (5)
5.6% (9)
Pruritus
19.3% (16)
4.9% (8)
Diarrhea
4.8% (4)
3.7% (6)
Alopecia
7.2% (6)
2.5% (4)

*Other than pruritus and alopecia, which were substantially more common in dogs receiving placebo.

†Occurrence calculated on a per case basis—no matter how many observations of the same abnormal health event a dog had, it contributed 1 observation to the occurrence calculation.

You may also be interested in
PET OWNER SATISFACTIONRESOURCES FOR PET OWNERS

References: 1. Souza CP, Rosychuk RAW, Contreras ET, et al. A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA. Vet Dermatol. 2018;29(6):489-e164. doi:10.1111/vde.12682. 2. Data on file, Study No. C961R-US-13-051, 2014, Zoetis Inc.

Cytopoint Indications

Cytopoint has been shown to be effective for the treatment of dogs against allergic dermatitis and atopic dermatitis.

More

Cytopoint Indications

Cytopoint has been shown to be effective for the treatment of dogs against allergic dermatitis and atopic dermatitis.